Fulgent Genetics Inc (FLGT)

$23.18 -0.09 (-0.39%)
Market Cap 719.32M
Revenue (ttm) 283.47M
Net Income (ttm) -42.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15.07%
Debt to Equity Ratio 0.00
Volume 227,900
Avg Vol 206,122
Day's Range N/A - N/A
Shares Out 30.91M
Stochastic %K 55%
Beta 0.86
Analysts Sell
Price Target $33.67

Company Profile

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer serv...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 626 350 0537
Fax: 626 454 1667
Address:
4399 Santa Anita Avenue, El Monte, United States
gammaeddy
gammaeddy Feb. 20 at 4:14 PM
$FLGT Fulgent Genetics provides diagnostic testing services. Revenue growth has normalized post-pandemic. Margin stability is the key driver.
1 · Reply
Sexydream
Sexydream Feb. 20 at 3:31 PM
$FLGT this pos is down 13% while its index Russell 2000 is up 8. That's an under performance of over 20%!!!! And here we have our idiot @jf152 saying it's low volume, short term manipulation, and that it's going to 100. Listen to yourself. You sound like you need help. Hahahahahhaahbababa
0 · Reply
Sexydream
Sexydream Feb. 18 at 5:32 PM
$FLGT Shorting this junk has been the easiest money I've ever made in my life bar none. That's because we have clowns like @jf152 who thinks this is "short term manipulation". It's been down 5 yrs straight. He must think 5 years is short term. That's why he is our class 🤡. In 5 yrs this will be at 25 bux a share still and he will be saying short term manipulation. Great stock. 🤣
0 · Reply
jf152
jf152 Feb. 14 at 7:37 PM
$FLGT A case study in low volume suspicious action on this stock. Something like 16,000 shares moved in the final 11 minutes of trading. That's over 10% of the total volume on the day. Many minutes during the day show no volume. It doesn't take a lot to manipulate the stock price in the short term.
1 · Reply
jf152
jf152 Feb. 12 at 5:16 PM
$FLGT This evil liar doesn't understand that short term price manipulation is meaningless in the long term. Same reason I didn't sell $DAC: the price moves down arent reality.
0 · Reply
Sexydream
Sexydream Feb. 12 at 5:10 PM
$FLGT @jf152 This is our 🤡 who thinks the stock is going to $100.
0 · Reply
jf152
jf152 Feb. 11 at 10:04 PM
$FLGT The stock fell six cents on very low volume, and this guy not merely posts this insane rant, and then likes his own post.
1 · Reply
Sexydream
Sexydream Feb. 11 at 3:21 PM
$FLGT @Endergast07 Good job on holding out like I told you. Your 22.50 is almost here. @jf152 do you see what happens when you listen to daddy? You make money. When will you start listening? You don't like money? 🤡🤡🤡
0 · Reply
Sexydream
Sexydream Feb. 9 at 3:45 PM
$FLGT 13th straight down day! Institutions are dumping this and our class clown @jf152 thinks it's "short term manipulation" LOLOLLL. See you below 20 very soon. Remember, big money knows more than you and me. And they're dumping.
1 · Reply
ClarityOfPurpose
ClarityOfPurpose Feb. 7 at 3:22 AM
$FLGT This was my only position in the red today. So now building up a bigger long investment here again, brick by brick. I love to swing trade this stock every few months.
1 · Reply
Latest News on FLGT
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

Feb 12, 2026, 7:30 AM EST - 9 days ago

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock

Jan 27, 2026, 3:59 AM EST - 25 days ago

Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Dec 22, 2025, 4:10 PM EST - 2 months ago

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 11, 2025, 9:04 AM EST - 3 months ago

Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript

Fulgent to Participate in Upcoming Conferences

Nov 7, 2025, 4:05 PM EST - 3 months ago

Fulgent to Participate in Upcoming Conferences

Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 2:56 PM EST - 3 months ago

Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

Fulgent Reports Third Quarter 2025 Financial Results

Nov 7, 2025, 7:05 AM EST - 3 months ago

Fulgent Reports Third Quarter 2025 Financial Results

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Oct 20, 2025, 6:00 AM EDT - 4 months ago

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Oct 16, 2025, 7:00 AM EDT - 4 months ago

Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025

Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

Sep 8, 2025, 1:58 PM EDT - 5 months ago

Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 12:28 PM EDT - 7 months ago

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Reports Second Quarter 2025 Financial Results

Aug 1, 2025, 7:00 AM EDT - 7 months ago

Fulgent Reports Second Quarter 2025 Financial Results

Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Jul 17, 2025, 7:00 AM EDT - 7 months ago

Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Jul 10, 2025, 4:05 PM EDT - 8 months ago

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out

Jun 10, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation

Jun 9, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 9 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation

Jun 6, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect

Jun 5, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation

Jun 4, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Investors to Learn More About the Investigation

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 2, 2025, 10:00 AM EDT - 9 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

May 30, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 29, 2025, 10:00 AM EDT - 9 months ago

Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

May 28, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

May 27, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

May 24, 2025, 9:19 PM EDT - 9 months ago

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

May 19, 2025, 8:11 AM EDT - 9 months ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

May 2, 2025, 12:27 PM EDT - 10 months ago

Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript

Fulgent Reports First Quarter 2025 Financial Results

May 2, 2025, 7:00 AM EDT - 10 months ago

Fulgent Reports First Quarter 2025 Financial Results

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Apr 10, 2025, 4:05 PM EDT - 11 months ago

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025

Stock Picks From Seeking Alpha's March 2025 New Analysts

Apr 4, 2025, 2:30 PM EDT - 11 months ago

Stock Picks From Seeking Alpha's March 2025 New Analysts

AI ARGX CCL CEPU CF CROX CUK

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Mar 20, 2025, 5:46 AM EDT - 1 year ago

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 11:57 AM EST - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 28, 2025, 7:00 AM EST - 1 year ago

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Feb 6, 2025, 4:05 PM EST - 1 year ago

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Feb 4, 2025, 4:00 PM EST - 1 year ago

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside

Dec 24, 2024, 1:25 AM EST - 1 year ago

Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside

Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 2:07 AM EST - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript

Fulgent Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 7:00 AM EST - 1 year ago

Fulgent Reports Third Quarter 2024 Financial Results

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Fulgent Genetics: An NCAV Pick With Profit And Growth Potential

Sep 25, 2024, 11:32 AM EDT - 1 year ago

Fulgent Genetics: An NCAV Pick With Profit And Growth Potential

Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Sep 9, 2024, 12:05 PM EDT - 1 year ago

Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst

Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 10:24 AM EDT - 1 year ago

Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript

Fulgent Reports Second Quarter 2024 Financial Results

Aug 2, 2024, 7:00 AM EDT - 1 year ago

Fulgent Reports Second Quarter 2024 Financial Results

gammaeddy
gammaeddy Feb. 20 at 4:14 PM
$FLGT Fulgent Genetics provides diagnostic testing services. Revenue growth has normalized post-pandemic. Margin stability is the key driver.
1 · Reply
Sexydream
Sexydream Feb. 20 at 3:31 PM
$FLGT this pos is down 13% while its index Russell 2000 is up 8. That's an under performance of over 20%!!!! And here we have our idiot @jf152 saying it's low volume, short term manipulation, and that it's going to 100. Listen to yourself. You sound like you need help. Hahahahahhaahbababa
0 · Reply
Sexydream
Sexydream Feb. 18 at 5:32 PM
$FLGT Shorting this junk has been the easiest money I've ever made in my life bar none. That's because we have clowns like @jf152 who thinks this is "short term manipulation". It's been down 5 yrs straight. He must think 5 years is short term. That's why he is our class 🤡. In 5 yrs this will be at 25 bux a share still and he will be saying short term manipulation. Great stock. 🤣
0 · Reply
jf152
jf152 Feb. 14 at 7:37 PM
$FLGT A case study in low volume suspicious action on this stock. Something like 16,000 shares moved in the final 11 minutes of trading. That's over 10% of the total volume on the day. Many minutes during the day show no volume. It doesn't take a lot to manipulate the stock price in the short term.
1 · Reply
jf152
jf152 Feb. 12 at 5:16 PM
$FLGT This evil liar doesn't understand that short term price manipulation is meaningless in the long term. Same reason I didn't sell $DAC: the price moves down arent reality.
0 · Reply
Sexydream
Sexydream Feb. 12 at 5:10 PM
$FLGT @jf152 This is our 🤡 who thinks the stock is going to $100.
0 · Reply
jf152
jf152 Feb. 11 at 10:04 PM
$FLGT The stock fell six cents on very low volume, and this guy not merely posts this insane rant, and then likes his own post.
1 · Reply
Sexydream
Sexydream Feb. 11 at 3:21 PM
$FLGT @Endergast07 Good job on holding out like I told you. Your 22.50 is almost here. @jf152 do you see what happens when you listen to daddy? You make money. When will you start listening? You don't like money? 🤡🤡🤡
0 · Reply
Sexydream
Sexydream Feb. 9 at 3:45 PM
$FLGT 13th straight down day! Institutions are dumping this and our class clown @jf152 thinks it's "short term manipulation" LOLOLLL. See you below 20 very soon. Remember, big money knows more than you and me. And they're dumping.
1 · Reply
ClarityOfPurpose
ClarityOfPurpose Feb. 7 at 3:22 AM
$FLGT This was my only position in the red today. So now building up a bigger long investment here again, brick by brick. I love to swing trade this stock every few months.
1 · Reply
jf152
jf152 Feb. 6 at 9:27 PM
$FLGT no honest individual would confuse short term price manipulation with long term prospects. Only evil liars do this . To be clear: this is no bear case for Fulgent. There IS a bear case for this guy's soul, however.
1 · Reply
Sexydream
Sexydream Feb. 6 at 8:59 PM
$FLGT 12 CONSECUTIVE DOWN DAYS!! @jf152 Definitely doesn't look like a stock that's going to $100. HAHAHAHAHAHAHHAHAHA
0 · Reply
Sexydream
Sexydream Feb. 6 at 3:34 PM
$FLGT market flying and the market is in line to dump this junk. Heavy volume too. Our clown @jf152 thinks this is going to $100. It may go to 100....in your dreams but in reality we are going below $20 in the coming weeks. I don't wanna be a broken record... But I told you so.
0 · Reply
jf152
jf152 Feb. 6 at 2:14 AM
$FLGT it is OBVIOUSLY going to $100. Literally all of the smart money agrees, including the insiders.
1 · Reply
Endergast07
Endergast07 Feb. 5 at 8:34 PM
$FLGT @Sexydream is feasting on the longs. I am waiting for 22.50 to add to my position. My portfolio is about 7% down today, from this you can deduce that FLGT is quite a large position :)
1 · Reply
jf152
jf152 Feb. 5 at 5:15 PM
$FLGT It is going to at LEAST $100 in the next three years.
1 · Reply
jf152
jf152 Feb. 5 at 5:10 PM
$FLGT
0 · Reply
Sexydream
Sexydream Feb. 5 at 5:03 PM
$FLGT $20 is right around the corner folks! Hope you listened to me and sold / shorted. Unlike our class clown @jf152 who thinks this is going to 100. Hahahahahahahhahahahahahha
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 5 at 4:23 PM
$FLGT RSI: 9.59, MACD: -0.5016 Vol: 1.11, MA20: 27.22, MA50: 27.48 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
jf152
jf152 Feb. 5 at 3:49 PM
$FLGT This explains the price run up. A major hedge fund took a substantial share. 3%! Smart money chasing value. More proof that the price manipulators and shorts like @Sexydream literally have no clue what they are doing. "As of 2022, Millennium had posted the fourth highest net gains of any hedge fund since its inception in 1989." https://ir.fulgentgenetics.com/node/11071/html
1 · Reply
Sexydream
Sexydream Feb. 4 at 9:18 PM
$FLGT taking bets! How many days till we see $24?! 🤣 9 straight down days. Can't make this stuff up folks! All you who trolled me when I said it's going back down to 25. Where yall at? 🤡🤡🤡 @jf152
0 · Reply
GalaxyGrowth
GalaxyGrowth Feb. 4 at 3:28 PM
$FLGT is a clinical laboratory services provider; it faces a post-pandemic normalization of testing volumes and competitive pressures in the diagnostic lab space.
0 · Reply